Lucas Franki
![1]()
News
FDA approves new antibiotic for HABP/VABP treatment
June 5, 2020
Recarbrio was previously approved by the FDA to treat patients with complicated urinary tract infections and complicated intra-abdominal infections.
![1]()
News
FDA grants EUA to muscle stimulator to reduce mechanical ventilator usage
May 5, 2020
VentFree allows patients to begin treatment during the early stages of ventilation while they are sedated and to continue until the patient is weaned off of ventilation.
![1]()
News
FDA authorizes first COVID-19 test kit with home collection option
April 21, 2020
The Pixel test includes a specific Q-tip–style cotton swab for patients to use to collect their samples.
News
SARS-CoV-2 escapes cotton, surgical masks of infected
April 8, 2020
All outer surfaces of masks used in the study were positive for SARS-CoV-2.
![1]()
News
FDA issues EUA allowing hydroxychloroquine sulfate, chloroquine phosphate treatment in COVID-19
March 31, 2020
The Strategic National Stockpile will work with FEMA to ship the products to states.
News
Dapagliflozin trial in CKD halted because of high efficacy
March 30, 2020
An independent data monitoring committee recommended stopping the trial.
![1]()
News
Despite strict controls, some infants born to mothers with COVID-19 appear infected
March 27, 2020
But the sources of novel coronavirus 2019 in the neonates’ upper respiratory tracts or anuses likely were maternal in origin.
![1]()
News
FDA issues warning on fecal transplant transmission of SARS-CoV-2
March 25, 2020
The FDA has issued several recommendations for any medically necessary usage of fecal microbiota transplantation.
News
FDA advises stopping SGLT2 inhibitor treatment prior to surgery
March 18, 2020
The changes affect canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin, and were made because surgery may put patients taking SGLT2 inhibitors at a higher risk of ketoacidosis.
![1]()
News
FDA warns of serious infection risk after FMT
March 13, 2020
The FDA has issued a Safety Alert warning of the potential risk of serious, life-threatening infection in patients with Clostridioides difficile infection who receive fecal microbiota transplant.
